Bourgeon Capital Management’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-15,200
| Closed | -$189K | – | 466 |
|
|
2022
Q2 | $189K | Sell |
15,200
-9,818
| -39% | -$122K | 0.05% | 92 |
|
|
2022
Q1 | $333K | Buy |
25,018
+2,868
| +13% | +$38.2K | 0.08% | 79 |
|
|
2021
Q4 | $345K | Buy |
22,150
+8,000
| +57% | +$125K | 0.07% | 88 |
|
|
2021
Q3 | $318K | Sell |
14,150
-250
| -2% | -$5.62K | 0.07% | 91 |
|
|
2021
Q2 | $328K | Buy |
14,400
+6,400
| +80% | +$146K | 0.07% | 97 |
|
|
2021
Q1 | $165K | Buy |
8,000
+6,750
| +540% | +$139K | 0.04% | 121 |
|
|
2020
Q4 | $35K | Sell |
1,250
-7,650
| -86% | -$214K | 0.01% | 161 |
|
|
2020
Q3 | $125K | Buy |
+8,900
| New | +$125K | 0.04% | 102 |
|